Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M759Revenue (TTM) $M7.5Net Margin (%)-2,292.3Altman Z-Score-7.7
Enterprise Value $M650EPS (TTM) $-1.3Operating Margin %-2,293.1Piotroski F-Score4
P/E(ttm)--Beneish M-Score-5.6Pre-tax Margin (%)-2,292.3Higher ROA y-yY
Price/Book--10-y EBITDA Growth Rate %-9.6Quick Ratio7.9Cash flow > EarningsY
Price/Sales1015-y EBITDA Growth Rate %-1.4Current Ratio7.9Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-118.5Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-269.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M132ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with ZIOP

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ZIOPJoel Greenblatt 2016-06-30 Reduce-0.01%$5.31 - $8.92
($7.26)
$ 5.76-21%Reduce -55.68%42,723
ZIOPJoel Greenblatt 2016-03-31 Reduce$4.89 - $9.59
($6.81)
$ 5.76-15%Reduce -12.49%96,406
ZIOPJoel Greenblatt 2015-12-31 Buy 0.01%$8.07 - $14.57
($11.04)
$ 5.76-48%New holding110,163
ZIOPJoel Greenblatt 2015-06-30 Sold Out -0.01%$8.81 - $12.5
($10.36)
$ 5.76-44%Sold Out0
ZIOPJoel Greenblatt 2015-03-31 Buy 0.01%$4.96 - $14
($9.88)
$ 5.76-42%New holding109,080
ZIOPFirst Eagle Investment 2013-06-30 Sold Out -0.0012%$1.52 - $2.62
($1.86)
$ 5.76210%Sold Out0
ZIOPFirst Eagle Investment 2013-03-31 Buy $1.72 - $5.71
($4.42)
$ 5.7630%New holding200,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ZIOP is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ZIOP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BELBEL CAESAR JCOO, CLO, and Secretary 2015-11-19Sell153,333$12.84-55.14view
LEBEL FRANCOISExecutive Vice President R&D 2015-06-09Sell50,000$10.12-43.08view
BRENNAN MURRAYDirector 2015-06-04Sell40,000$9.7-40.62view
Lafond Kevin GVice Pres., Treasurer, & CAO 2015-06-03Sell57,500$9.65-40.31view
KIRK RANDAL JDirector, 10% Owner 2015-02-09Buy1,440,000$8.75-34.17view
KIRK RANDAL JDirector, 10% Owner 2013-10-29Buy2,857,143$3.564.57view
KIRK RANDAL JDirector, 10% Owner 2012-01-20Buy1,923,075$5.210.77view
KIRK RANDAL JDirector, 10% Owner 2011-08-23Buy38,294$4.9915.43view
KIRK RANDAL JDirector, 10% Owner 2011-08-22Buy461,646$4.9217.07view
Fowler WycheDirector 2011-08-10Buy5,000$5.1910.98view

Quarterly/Annual Reports about ZIOP:

News about ZIOP:

Articles On GuruFocus.com
Intrexon Corp is expanding his business Jun 25 2015 
Hayman Advisors Update - Second Quarter Sells and Company Results Aug 26 2013 
Bass’ New Buy – ZIOPHARM Oncology Inc. May 16 2013 
The Far-Off Four, 52-week Lows Held by Gurus May 11 2013 

More From Other Websites
ZIOPHARM Oncology, Inc. – Value Analysis (NASDAQ:ZIOP) : September 12, 2016 Sep 12 2016
Ziopharm put sale bets on end to slide Sep 09 2016
ZIOPHARM Oncology, Inc. breached its 50 day moving average in a Bullish Manner : ZIOP-US : September... Sep 09 2016
ZIOPHARM to Present at the 2016 Wells Fargo Healthcare Conference Aug 31 2016
ZIOPHARM ONCOLOGY INC Financials Aug 18 2016
ZIOPHARM Oncology, Inc. breached its 50 day moving average in a Bullish Manner : ZIOP-US : August... Aug 16 2016
ETF’s with exposure to ZIOPHARM Oncology, Inc. : August 15, 2016 Aug 15 2016
ZIOPHARM Oncology, Inc. :ZIOP-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 Aug 12 2016
Ziopharm Oncology (ZIOP) Stock Advances After Q2 Results, Upgrade Aug 10 2016
ZIOPHARM upgraded by Wells Fargo Aug 10 2016
Ziopharm reports 2Q loss Aug 09 2016
Ziopharm reports 2Q loss Aug 09 2016
ZIOPHARM Reports Second-Quarter 2016 Financial Results and Provides Update on Recent Activities Aug 09 2016
ZIOPHARM ONCOLOGY INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Aug 09 2016
ZIOPHARM ONCOLOGY INC Files SEC form 10-Q, Quarterly Report Aug 09 2016
ZIOPHARM Reports Second-Quarter 2016 Financial Results and Provides Update on Recent Activities Aug 09 2016
Lifshitz & Miller Law Firm Announces Investigation of American Renal Associates Holdings, Inc.,... Aug 05 2016
First-In-Human Trials using Non-Viral Sleeping Beauty System to Express CD19-Specific CAR in T cells... Aug 04 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)